Taking Advantage of the EU MDR Delay in Uncertain Times – Webinar
Register for the webinar
Downloadable Resources and Registration
"*" indicates required fields
Overview
Where
Online
When
N/A
Join us for an insightful discussion where regulatory experts unveil how Lean Authoring is revolutionizing submission processes for pharmaceutical and medical device industries.
This webinar explores actionable strategies for creating optimized, compliant submissions, with a focus on structuring data for faster regulatory approvals and streamlined workflows.
Through real-world case studies, our speakers illustrate how Lean Authoring reduces document duplication, improves submission accuracy, and ensures faster decision-making—empowering your team to stay ahead of regulatory requirements.
Whether you’re responsible for regulatory submissions, data governance, or compliance management, this session will equip you with the knowledge to implement Lean Authoring effectively and achieve measurable results.
Don’t miss this opportunity to enhance your submission efficiency and align with global Health Authority standards.
Don’t miss this opportunity to enhance your regulatory skills and understanding.
What You Will Learn
Gain actionable knowledge and insights with our webinar:
- Streamlined Workflows: Learn how Lean Authoring accelerates submission processes by organizing data for improved efficiency and reduced turnaround times.
- Document Reusability: Explore strategies to enhance document reuse across multiple submissions, cutting down on duplication and manual effort.
- Regulatory Compliance Simplified: Gain insights into creating submissions that meet evolving Health Authority standards while minimizing non-compliance risks.
- Resource Optimization: See how Lean Authoring helps teams save time and resources by focusing on critical submission components.
- Actionable Best Practices: Discover practical methods to implement Lean Authoring in your organization for measurable results and streamlined regulatory operations.
Webinar Speakers
Chief Scientific Officer, Celegence
Hans van Bruggen
Head of Regulatory Affairs, Celegence
Marloes van der Geer
Authored By
Other Related Articles
25 Apr, 2025
Privacy Overview
Please complete the form:
And our team will get back to you soon.